Figure 2.
The tumor inhibition of the combined treatment by subcutaneously inoculated ADSC-E7’-eGFP and the protein vaccine. (A) Time course of the experiment. Representative bioluminescence images of mice subcutaneously injected with (B) 2 × 105 CT26 cells with indicated treatment or (C) 2 × 105 LLC1 cells with indicated treatment. Tumor volume measurements of syngeneic tumor models were conducted at indicated days after subcutaneous injection of (D) CT26 cells or (E) LLC1 cells; ** p < 0.01; *** p < 0.001 using two-way ANOVA.